Highlights

• Institutional ownership, healthcare technology and digital infrastructure developments put three ASX stocks in focus.
• PDI Gold disclosed a new substantial holder, while 4DMedical reported strong FY26 operating growth.
• Megaport released an update on changes to a director’s performance rights holdings.

ASX Stocks in Focus

Several ASX-listed companies recorded notable share price gains, with PDI Gold Limited (ASX: PDI), 4DMedical Limited (ASX: 4DX) and Megaport Limited (ASX: MP1) among the stocks attracting market attention. PDI Gold shares last traded at AU$4.950, rising AU$0.580, or 13.27%. Meanwhile, 4DMedical shares were trading at AU$4.210, up AU$0.410, or 10.79%, while Megaport shares climbed AU$1.460, or 8.47%, to AU$18.690.

PDI Gold Reports Substantial Holder Disclosure

An ASX Form 603 dated 14 September 2026 disclosed that State Street Bank and Trust Company became a substantial holder in PDI Gold on 10 September 2026. The notice reported voting power of 5.27%, with relevant interests held through State Street and associated entities. The disclosure provides an update on the company's shareholder structure as institutional interests in the company are reported to the market.

4DMedical Reports FY26 Growth

4DMedical released its FY26 full-year results on 28 August 2026, reporting operating revenue of AU$7.1 million, representing a 21% increase from FY25. The company also produced 344,075 scans during FY26, up 77% year-on-year, while its SaaS products were being delivered at 540 sites globally as of 30 June 2026. The company also highlighted the commercial expansion of its CT:VQ technology, including adoption by US academic medical centres and regulatory approvals across additional international markets.

Megaport Updates Director Interests

Megaport's Appendix 3Y disclosed a change in director Michael Reid's interests dated 3 September 2026. The notice stated that 24,069 PRSUs were disposed of, leaving him with 335,341 ordinary shares and 1,624,600 PRSUs. The filing noted that the PRSUs formed part of Megaport's Restricted Stock Unit Program. Several tranches vested on 3 September 2026, while 24,069 PRSUs lapsed after their vesting conditions were not met.

Market Outlook

The latest share price movements place the three companies under focus, with their respective announcements covering shareholder disclosures, operational performance and director interests. Further company announcements and sector developments could remain important for investors tracking these ASX-listed stocks.

Note- All data presented is based on information available at the time of writing.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au